Maternal Depression - Child Development - Mother-Child Relationship PND
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Kenya inclusion criteria: 1. Mothers who have recently given birth, living in one of the two research sites 2. Fathers who have recently had a child, living in one of the two research sites 3. Healthcare workers without mental health expertise, who work in one of the two research sites 4. Healthcare workers with mental health expertise, who work in one of the two research sites 5. Religious leaders working in one of the two research sites 6. Traditional midwives working in one of the two research sites 7. Key informants, such as staff working in local or national organisations in a related field (mental health, maternal health and early childhood health)
Exclusion criteria
Exclusion criteria: Participant exclusion criteria Feasibility trial: 1. Mothers with psychotic conditions including bipolar disorder, anorexia nervosa or substance dependency 2. Mothers whose babies have severe physical health problems or neurodevelopmental problems
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Name: Severity of depression;Timepoints: baseline and at 8 (T2), 13 (T3), and 24 (T4) weeks post-treatment;Measure: Patient Health Questionnaire- depression module (PHQ-9) | — |
Secondary
| Measure | Time frame |
|---|---|
| Name: Family circumstances;Timepoints: baseline (T1) and 13 weeks (T3);Measure: family circumstances questionnaire;Name: Height and weight measures of infants ;Timepoints: baseline (T1) and 13 weeks (T3);Measure: following WHO guidelines;Name: Early childhood development outcomes ;Timepoints: baseline (T1), 8 weeks (T2), 13 weeks (T3) and 24 weeks (T4);Measure: Caregiver Reported Early Development Index (CREDI) long form;Name: Depression;Timepoints: baseline (T1), 8 weeks (T2), 13 weeks (T3) and 24 weeks (T4);Measure: Hamilton Depression Rating Scale (HRSD);Name: Anxiety;Timepoints: baseline (T1), 8 weeks (T2), 13 weeks (T3) and 24 weeks (T4);Measure: General Anxiety Disorder-7 (GAD-7);Name: Sleep;Timepoints: baseline (T1), 8 weeks (T2), 13 weeks (T3) and 24 weeks (T4);Measure: Sleep Condition Indicator (SCI);Name: Generic health status;Timepoints: baseline (T1), 8 weeks (T2), 13 weeks (T3) and 24 weeks (T4);Measure: Short-Form Health Survey (SF-36);Name: Infant’s sleep;Timepoints: baseline (T1), 8 weeks (T2), 13 weeks (T3) and 24 weeks (T4);Measure: Brief Infant Sleep Questionnaire – Revised Short form (BISQ);Name: Infant’s physical health;Timepoints: baseline (T1), 8 weeks (T2), 13 weeks (T3) and 24 weeks (T4);Measure: infant physical health questionnaire;Name: Infant’s cognitive development;Timepoints: 24 weeks (T4);Measure: Malawi Developmental Assessment Tool (MDAT);Name: Breastfeeding ;Timepoints: baseline (T1), 8 weeks (T2), 13 weeks (T3) and 24 weeks (T4);Measure: breastfeeding outcome measure;Name: Social isolation;Timepoints: baseline (T1) and 13 weeks (T3);Measure: Lubben Social Network Scale (LSNS-6) ;Name: Relationship satisfaction;Timepoints: baseline (T1) and 13 weeks (T3);Measure: Couple Satisfaction Index (CSI-16);Name: Health outcome;Timepoints: baseline (T1) and 13 weeks (T3);Measure: EQ-5D;Name: Capability;Timepoints: baseline (T1), 13 weeks (T3) and 24 weeks (T4);Measure: ICEpop CAPability measure for Adults (ICECAP-A);Name: Value of intervent | — |
Countries
Kenya, Lebanon
Contacts
NMHP-MoPH